Lupus News and Research

Latest Lupus News and Research

Study applying OPKO Health's technology to identify synthetic peptoid in NMO patient serum published

OPKO Health, Inc. today announced the publication of a study applying its novel library screening technology to identify a synthetic peptoid that binds to anti-Aquaporin 4 antibodies in the serum of patients with Neuromyelitis optica.

6 Apr 2013

Schizophrenia patients experiencing relapse are more likely to develop UTIs

Schizophrenia patients experiencing relapse are 29 times more likely than healthy individuals to have a urinary tract infection, researchers report.

4 Apr 2013

Same factor that helps fight off severe inflammatory ailments also functions as enemy

The same factor in our immune system that is instrumental in enabling us to fight off severe and dangerous inflammatory ailments is also a player in doing the opposite at a later stage, causing the suppression of our immune response.

4 Apr 2013

Researchers identify link between immune response and blood clotting

Rice University researchers have found an unexpected link between a protein that triggers the formation of blood clots and other proteins that are essential for the body's immune system.

2 Apr 2013

Two nationally renowned specialists to research on Lupus, auto-immune disorders

In a new association of nationally renowned specialists on Lupus and auto-immune disorders, Dr. Swamy Venuturupalli , is joining with Dr. Daniel Wallace to accelerate research into those diseases along with their expanded clinical practice.

1 Apr 2013

Hospitals often don't tell patients about assistance programs to help pay bills

ABC reports that although nonprofit hospitals are obligated to give back to the community, they often don't ease the strain for patients with financial difficulties. And in other news, The New York Times looks at efforts to cut emergency room care costs.

30 Mar 2013

Mayo Clinic neurology experts present research findings at AAN meeting

Mayo Clinic neurology experts will present research findings on Parkinson's disease, Alzheimer's disease, sleep disorders, concussions, multiple sclerosis and more at the American Academy of Neurology annual meeting in San Diego, March 16-23.

20 Mar 2013

AARDA launches 2013 Autoimmune Walk: Linking Together for a Cure Campaign calendar

As part of its National Autoimmune Disease Awareness Month activities, American Autoimmune Related Diseases Association has launched its 2013 "Autoimmune Walk: Linking Together for a Cure" Campaign calendar with more than double the number of events taking place this year from New York to California.

16 Mar 2013

UCSF study on T-cell behavior sheds light on how vaccines work

The immune system's T cells, while coordinating responses to diseases and vaccines, act like honey bees sharing information about the best honey sources, according to a new study by scientists at UC San Francisco.

14 Mar 2013

CALHM1 protein controls sense of taste, finds study

In collaboration with other research institutions, a Feinstein Institute for Medical Research investigator discovered a new protein that controls the sense of taste. The findings are published in the March issue of Nature.

7 Mar 2013

Gene cluster implicated in Behçet's disease

Scientists may have uncovered an underlying genetic susceptibility for Behçet's disease in East Asian patients.

5 Mar 2013

Idera announces new data from IMO-3100 and IMO-8400 preclinical study on psoriasis

Idera Pharmaceuticals, Inc. today announced the presentation of new data showing that its selective Toll-like receptor antagonists, IMO-3100 and IMO-8400, normalized the gene expression of important cytokines in a preclinical study of skin inflammation that is commonly used as a model of psoriasis.

4 Mar 2013

Nanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus

Systemic lupus erythematosus (SLE) is disease in which the immune system mistakenly attacks healthy tissues, resulting in inflammation and tissue damage. Current treatments are focused on suppression of the immune system, but these therapies can leave patients vulnerable to infection.

2 Mar 2013

Resolve Therapeutics, Takeda partner to develop compounds for treatment of lupus

Takeda Pharmaceutical Company Limited and Resolve Therapeutics, LLC today jointly announced that they have entered into a partnership to develop compounds for the treatment of lupus (also known as Systemic Lupus Erythematosus, or SLE) and other autoimmune diseases.

27 Feb 2013

UCB seeks FDA and EMA marketing authorization for Cimzia to treat active psoriatic arthritis

UCB announced today two new regulatory filings with the US Food and Drug Administration (FDA) and with the European Medicines Agency (EMA) to extend the marketing authorization for Cimzia (certolizumab pegol) for the treatment of adult patients with active psoriatic arthritis (PsA) and for adult patients with active axial spondyloarthritis (axSpA).

20 Feb 2013

Antibody test ‘inappropriate’ without connective tissue symptoms

The positive antinuclear antibody test is often used inappropriately in patients without indications of connective tissue disease, real-world research suggests.

18 Feb 2013

Two studies discover new enzyme that acts as a sensor of innate immunity

Two studies by researchers at UT Southwestern Medical Center could lead to new treatments for lupus and other autoimmune diseases and strengthen current therapies for viral, bacterial, and parasitic infections.

16 Feb 2013

AARDA to mark National Autoimmune Disease Awareness Month with new initiatives

March is National Autoimmune Disease Awareness Month 2013. To mark the annual event, the American Autoimmune Related Diseases Association Inc. (AARDA) is encouraging the national and local media around the country to report stories on autoimmune diseases (AD) and autoimmunity as a category of disease.

13 Feb 2013

Infusions of regulatory T cells turn off autoimmune attack on joints

Farber Cancer Institute scientists have demonstrated a new strategy for treating autoimmune disease that successfully blocked the development of rheumatoid arthritis in a mouse model. They say it holds promise for improved treatment of arthritis and other autoimmune disorders in people.

10 Feb 2013

Scientists identify specific cellular events that appear key to lupus

A team led by scientists at The Scripps Research Institute (TSRI) has identified specific cellular events that appear key to lupus, a debilitating autoimmune disease that afflicts tens of millions of people worldwide. The findings suggest that blocking this pathway in lupus-triggering cells could be a potent weapon against the disease.

5 Feb 2013

Lupus News and Research

Latest Lupus News and Research

Study applying OPKO Health's technology to identify synthetic peptoid in NMO patient serum published

Schizophrenia patients experiencing relapse are more likely to develop UTIs

Same factor that helps fight off severe inflammatory ailments also functions as enemy

Researchers identify link between immune response and blood clotting

Two nationally renowned specialists to research on Lupus, auto-immune disorders

Hospitals often don't tell patients about assistance programs to help pay bills

Mayo Clinic neurology experts present research findings at AAN meeting

AARDA launches 2013 Autoimmune Walk: Linking Together for a Cure Campaign calendar

UCSF study on T-cell behavior sheds light on how vaccines work

CALHM1 protein controls sense of taste, finds study

Gene cluster implicated in Behçet's disease

Idera announces new data from IMO-3100 and IMO-8400 preclinical study on psoriasis

Nanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus

Resolve Therapeutics, Takeda partner to develop compounds for treatment of lupus

UCB seeks FDA and EMA marketing authorization for Cimzia to treat active psoriatic arthritis

Antibody test ‘inappropriate’ without connective tissue symptoms

Two studies discover new enzyme that acts as a sensor of innate immunity

AARDA to mark National Autoimmune Disease Awareness Month with new initiatives

Infusions of regulatory T cells turn off autoimmune attack on joints

Scientists identify specific cellular events that appear key to lupus

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Lupus News and Research

Latest Lupus News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in